Schedule 13G ownership disclosure

Axsome Therapeutics Inc

Security class unavailable · CUSIP: 05464T104

Event date: 2023-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-079094
Form type
SC 13G
Filer
Axsome Therapeutics, Inc.
CIK
CIK 1579428
Filed
Jul 07, 2023
Reporting period
Jun 28, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub